Grant Street Asset Management, Inc. Abbott Laboratories Transaction History

Grant Street Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$90.19 - $110.4 $187,685 - $229,742	2,081 New	2,081 $229,000
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $10,178 - $11,341	101 Added 4.93%	2,148 $234,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $194,587 - $228,281	2,047 New	2,047 $224,000
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $52,895 - $62,265	-500 Reduced 19.63%	2,047 $237,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $195,023 - $249,606	2,547 New	2,547 $233,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Grant Street Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Grant Street Asset Management, Inc. with notifications on news.